HTS: BT STEPS

In October, 1998, Pfizer, Inc., Healthcare Technology Systems, Inc., Massachusetts General Hospital and the Institute of Psychiatry of London concluded a multi-site, randomized, controlled trial to examine the benefits of a computer-assisted behavioral treatment program (BT STEPS™), clinician-administered behavior therapy and systematic relaxation for the treatment of Obsessive Compulsive Disorder (OCD). The study included nearly 200 patients at 8 sites. Patients were randomized into one of three treatment arms. Treatment lasted 12 weeks. Results have been published and both computer and clinician-administered therapies were significantly more helpful than relaxation.

BT STEPS™ publications

BT STEPS assists patients in the assessment of their OCD and then helps them design and implement their own treatment program. Support and monitoring is provided through a series of phone calls using Interactive Voice Response (IVR) technology. BT STEPS includes a Workbook to guide the treatment process. The program is available 24 hours a day by Touch-Tone phone. (No personal computer is needed.)

BT STEPS is not currently available to the public. Healthcare organizations and pharmaceutical companies interested in being added to the list of parties to be notified when BT STEPS is available should call (800) 316-2414 ext. 2478 (toll free) or e-mail sales@healthtechsys.com.